再春館共創ラボラトリー
Saishunkan Co-creation Laboratory is a Japan-based open innovation firm wholly owned by Saishunkan Pharmaceutical that orchestrates cross-industry co-creation with external partners across product development, R&D, and solution domains addressing Japan's super-aging society.
- Company typePrivate
- Founded2024
- HeadquartersTokyo, Japan
- Headcount—
- GTM typeB2B
- OfferingServices
What 再春館共創ラボラトリー does
Saishunkan Co-creation Laboratory Co., Ltd. (再春館共創ラボラトリー) is a Japan-based open innovation and co-creation services firm established on April 8, 2024, as a wholly-owned subsidiary of Saishunkan Pharmaceutical Co., Ltd. (再春館製薬所). The company plans and operates well-being and co-creation events and builds network environments that link external companies and research institutions to the broader Saishunkan Group ecosystem in order to accelerate mutual business growth and create new value. Its stated mission focuses on enabling people to "look forward to tomorrow" (明日が楽しみ) by addressing the challenges of Japan's super-aging society (超高齢社会), positioning itself as a vehicle for the parent group's open innovation ambitions.
The company's offering is organized around three co-creation domains: product development, R&D seed technologies, and problem-solving solutions. It does not sell discrete software or hardware products; instead, its "product" is the orchestration of cross-industry collaboration drawing on the capabilities of its parent and sister companies, which span pharmaceutical manufacturing (Saishunkan Pharmaceutical), HR services (Human Relation), IT/systems (Saishunkan Systems), safety research (Saishunkan Safety and Security Research Institute), sports (Saishunkan Sports CCI), bio-food manufacturing (Nihon Bio Foods Manufacturing), and advertising (Daiichi Agency). No proprietary technology stack, software platforms, patents, trademarks, AI/ML capabilities, or APIs are disclosed in any source material.
Revenue is generated through professional-services-style co-creation and open innovation engagements with external companies and research institutions, but specific revenue mechanics, pricing, contract values, customer counts, and financial performance are not publicly disclosed. The company is privately held, not listed on any stock exchange, and operates from the Tokyo office of Saishunkan Pharmaceutical in Minato-ku (Takanawa 4-chome). Distribution and go-to-market are executed through a relationship-driven model with inquiries routed via a contact form on its corporate website (scclab.co.jp), offering options for company briefings, co-creation inquiries, and other purposes. Registered capital is 100 million yen, fully contributed by the parent.
再春館共創ラボラトリー firmographics
Firmographics- Name
- 再春館共創ラボラトリー
- Legal name
- 株式会社 再春館共創ラボラトリー
- Website
- https://scclab.co.jp
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Short description
- Saishunkan Co-creation Laboratory is a Japan-based open innovation firm wholly owned by Saishunkan Pharmaceutical that orchestrates cross-industry co-creation with external partners across product development, R&D, and solution domains addressing Japan's super-aging society.
- Ownership category
- akta.pro rank
再春館共創ラボラトリー industry classification
Industry- Product category
- Open Innovation / Co-creation Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Innovation Leadership & Leading Growth (EDABAAAO)
- akta.pro secondary industry
- Research Collaboration & Joint Labs (International Partnerships) (EDAIABAC)
Keywords
Where 再春館共創ラボラトリー is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
再春館共創ラボラトリー business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Co-creation and open innovation services: Revenue is generated through co-creation partnerships with external companies and research institutions, facilitating mutual business growth and new value creation. The specific revenue mechanisms are not publicly detailed.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
再春館共創ラボラトリー product offering
Product offeringCore offering
Saishunkan Co-creation Laboratory operates an open-innovation platform that partners with external companies and research institutions to co-create new products, R&D seeds, and well-being solutions targeting Japan\u2019s super-aging society. It also plans and operates Well-being and co-creation events as engagement channels. The company is fully funded and capitalized by its parent, Saishunkan Pharmaceutical Co., Ltd.
Product overview
Saishunkan Co-creation Laboratory is an open innovation company established on April 8, 2024, as a subsidiary of Saishunkan Seiyakusho (Saishunkan Pharmaceutical). The company focuses on creating new value through co-creation with external companies and research institutions. Its core business involves building innovation networks across the Saishunkan Group and external partners to promote mutual business growth, with key co-creation domains spanning product development, R&D seeds, and solution-oriented approaches. The company aims to realize a 'Good Aging Society' where people look forward to tomorrow, particularly addressing challenges of Japan's super-aging society through cross-industry collaboration and paradigm-breaking innovations.
Differentiator
Problem solved
Functional benefit
Products and services
- Co-creation in the Product area (共創プロダクト領域) Open-innovation co-creation engagement area focused on jointly developing new products with external partner companies and research institutions, targeting solutions for Japan\u2019s super-aging society.
- Co-creation in the R&D Seeds area (研究開発シーズ領域) Open-innovation co-creation engagement area for cultivating and developing R&D seeds from external research institutions and companies, leveraging the Saishunkan Pharmaceutical group\u2019s scientific and well-being expertise.
- Co-creation in the Solution area (課題解決ソリューション領域) Solution-oriented co-creation engagement area in which the company works with external partners to solve defined problems related to Japan\u2019s super-aging society and the \u201Cgood aging\u201D vision.
- Well-being & co-creation event planning (Well-being & 共創イベント企画運営) Planning and operation of well-being and co-creation events designed to convene partners around the \u201Cgood aging\u201D theme and related super-aging society topics.
Companies that use 再春館共創ラボラトリー
Customer profileSegments1 record
Ideal customer profiles1 record
再春館共創ラボラトリー technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
再春館共創ラボラトリー partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered minor and core.
- 株式会社 ヒューマンリレーション (Human Relation Co., Ltd.)minorListed as a group company within the Saishunkan Group ecosystem. Provides HR-related services within the group network.
- 再春館システム株式会社 (Saishunkan Systems Co., Ltd.)minorListed as a group company within the Saishunkan Group ecosystem. Provides systems and IT services within the group network.
- 株式会社 再春館「安心・安全」研究所 (Saishunkan Safety and Security Research Institute Co., Ltd.)minorListed as a group company within the Saishunkan Group ecosystem. Conducts safety and security research within the group network.
- 株式会社 第一エージェンシー (Daiichi Agency Co., Ltd.)minorListed as a group company within the Saishunkan Group ecosystem. Provides agency/advertising services within the group network.
- 株式会社 再春館スポーツCCI (Saishunkan Sports CCI Co., Ltd.)minorListed as a group company within the Saishunkan Group ecosystem. Operates sports-related business within the group network.
- ニホンバイオフーヅ製造株式会社 (Nihon Bio Foods Manufacturing Co., Ltd.)minorListed as a group company within the Saishunkan Group ecosystem. Operates bio food manufacturing within the group network.
- External companies and research institutionscoreThe company actively collaborates with external companies and research institutions as a core part of its open innovation mission. These partnerships span product development, R&D seed technologies, and solution-focused collaboration to create new value and accelerate mutual business growth. The company explicitly seeks cross-industry co-creation beyond the boundaries of a single company.
Scale indicators1 record
Recent moves5 records
Expansion highlights6 records
再春館共創ラボラトリー competitors and assessment
Company assessmentDirect peers
- Plug and Play Japan: Corporate innovation accelerator with a Japan office that runs co-creation programs between corporates and startups. Directly comparable open innovation model.
- LIVERNESS Co., Ltd. Japanese startup support and ecosystem-building company that connects corporates with innovators. Comparable co-creation and partner-matching focus.
- Creww Inc. Japanese open innovation platform that matches startups with large enterprises for co-creation. Most directly comparable in mission and Japanese market focus.
- 01Booster Inc. Japan-based open innovation support and startup accelerator that partners large corporations with emerging companies. Highly comparable in mission and operating model.
Broad incumbents
- Dentsu Inc. Japan-headquartered global advertising and marketing group with significant innovation and co-creation initiatives. Comparable in Japanese market presence and innovation focus, but operates at vastly larger scale.
- IDEO: Global design and innovation consultancy that helps corporates develop new products and services through co-creation. Comparable mission but broader portfolio and global scale.
- Accenture (Innovation practice): Global consulting firm with Fjord and innovation practices that run co-creation with enterprise clients. Comparable open innovation offerings as part of a much broader portfolio.
- Recruit Holdings Co., Ltd. Japanese internet/media conglomerate with internal innovation and corporate venture functions. Comparable in Japan-based innovation orientation, but with a much broader HR/media portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
再春館共創ラボラトリー financial estimates
Financial estimateRevenue estimate
Valuation estimate
再春館共創ラボラトリー leadership team
Management profileNumber of profiles
Profiles3 records
再春館共創ラボラトリー funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
再春館共創ラボラトリー M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 再春館共創ラボラトリー
What does 再春館共創ラボラトリー do?
Saishunkan Co-creation Laboratory operates an open-innovation platform that partners with external companies and research institutions to co-create new products, R&D seeds, and well-being solutions targeting Japan\u2019s super-aging society. It also plans and operates Well-being and co-creation events as engagement channels. The company is fully funded and capitalized by its parent, Saishunkan Pharmaceutical Co., Ltd.
Is 再春館共創ラボラトリー a public or private company?
再春館共創ラボラトリー is a private company. It is classified as corporate owned and is currently operating.
When was 再春館共創ラボラトリー founded?
再春館共創ラボラトリー was founded in 2024.
Where is 再春館共創ラボラトリー based?
再春館共創ラボラトリー is headquartered in Tokyo, Japan, in the Asia region.
How does 再春館共創ラボラトリー make money?
One revenue line is on record: co-creation and open innovation services.
Who are 再春館共創ラボラトリー's main competitors?
Direct peers on record are Plug and Play Japan, LIVERNESS Co., Ltd., Creww Inc. and 01Booster Inc.. Broad incumbents are Dentsu Inc., IDEO, Accenture (Innovation practice) and Recruit Holdings Co., Ltd..
Does 再春館共創ラボラトリー have an API?
No public API is recorded for 再春館共創ラボラトリー.
What industry is 再春館共創ラボラトリー in?
再春館共創ラボラトリー's product category is Open Innovation / Co-creation Services. Its primary akta.pro industry code is EDABAAAO, Innovation Leadership & Leading Growth, with a secondary code of EDAIABAC, Research Collaboration & Joint Labs (International Partnerships). Its NAICS code is 5417 and its SIC code is 8731.